AI assistant
ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2023
Apr 24, 2023
33882_dirs_2023-04-24_9605573a-48a6-4637-8aae-47daf9958ad8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ACHIEVE LIFE SCIENCES, INC. (ACHV)
CIK: 0000949858
Period of Report: 2023-04-21
Reporting Person: Bencich John (Director, CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-04-21 | Common Stock | M | 25000 | $0.00 | Acquired | 61920 | Direct |
| 2023-04-21 | Common Stock | F | 7324 | $6.80 | Disposed | 54596 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-04-21 | Performance Restricted Stock Unit (PRSU) | $ | M | 25000 | Acquired | 2026-01-03 | Common Stock (25000) | Direct |
Footnotes
F1: Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II.
F2: Represents shares of common stock that have been withheld by the issuer to satisfy the tax liability in connection with the settlement of PRSUs.
F3: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement.
F4: Pursuant to the terms of the PRSU 50% of the total shares underlying the PRSU vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone.